Category: Cataract

Anacetrapib Raised HDL, Lowered LDL

The cholesteryl ester transfer protein (CETP) inhibitor
anacetrapib (Merck and Co., Whitehouse Station, New
Jersey) dramatically raised high-density lipoprotein (HDL)
cholesterol and lowered low-density lipoprotein (LDL)
cholesterol, according to a stu…

Ophthalmic Business Forecast for 2011

Each year brings with it several new and exiting technologies
in the cataract and refractive surgery market,
and many believe 2011 will be an especially
important , and in some ways revolutionary, year.
With an ever-increasing baby boom popula…

TOP QUOTATIONS

bStephen G. Slade,MD, September 2001/bbr /strongAny suggestions for young refractive surgeons?/strongbr /Go where you want to live, be thankful that you
are in this profession, find the right balance of
medicine to business that suit…

Help for Haiti

January 12, 2010, is a day no Haitian will ever forget.
For those distant from the day’s horror, it might
already seem like a fading memory, eclipsed by the oil
spill disaster, floods in the Midwest, and what seems
like a never-ending econom…

‘Tis Better to Give Than to Receive

This holiday season, reward yourself with the giftof Eyetube.net. Ophthalmic surgeons across theglobe have uploaded videos to present their surgicalpearls to you. Here are some great newadditions to this growing video resource.bLASER-ASSI…

Top Products of 2010

The year 2010 was another terrific one for new
products. At October’s annual meeting of the
American Academy of Ophthalmology in
Chicago, I reviewed nearly 100 new products that
affect cataract surgeons. This article describes some of
the h…